PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Title only   |   Print    Next page > 
     
Tianjin University Leads World's 1st ISO Standard for Single-Herb TCM Formula Granules
TIANJIN, China , Sept. 16, 2026 /PRNewswire/ -- The International Organization for Standardization (ISO) has published ISO 21756:2026, the world's first international standard for single-herb Traditional ...
2026-09-17T    Education   Health Care/Hospital   Higher Education   Medical/Pharmaceuticals 
OncoC4 Receives FDA Fast Track Designation for Cesalatamig, an Investigational PD-1/VEGF Bispecific Antibody
Cesalatamig is Currently Being Evaluated in Phase 1/2 Studies in the United States ( NCT06635785 ) and in China ( CTR20253261 ) Fast Track Designation Supports Expedited Development of Cesalatamig ...
2026-09-16T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Lundbeck receives marketing authorization for Vyepti® (eptinezumab) in Japan for the prevention of migraine attacks
Approval granted by Japan's Ministry of Health, Labour and Welfare (MHLW) Eptinezumab is the only intravenous (IV) CGRP-targeted preventive treatment approved for the prevention of migraine attacks ...
2026-09-16T    Health Care/Hospital   Medical/Pharmaceuticals 
GHIT Fund Launches "NTDpedia" to Help Turn Apathy Into Action Against Neglected Tropical Diseases
The interactive educational website makes NTDs understandable to a general audience, the first step toward public support that drives R&D for the 1.5 billion people affected by these disease ...
2026-09-16T    Biotechnology   Health Care/Hospital   Infectious Disease Control   Medical/Pharmaceuticals 
Ferronova announces preliminary results of MAGMAP, a 62-patient gastric and oesophageal cancer trial investigating lymph node mapping
KYOTO, Japan , Sept. 16, 2026 /PRNewswire/ -- Australian medical technology company Ferronova has announced preliminary findings from the MAGMAP multi-centre trial involving 62 gastric and oesophageal ...
2026-09-16T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Skyhawk Therapeutics Announces Final Fifteen-Month Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease Patients
The fifteen-month dataset represents the final analysis from the Phase 1/2 study At the Month 15 primary timepoint, SKY-0515-treated patients showed a +1.59-point difference in Composite Unified Huntington's ...
2026-09-16T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
CordenPharma Appoints Dr. Jean-Luc Herbeaux as Chief Executive Officer to Lead Next Phase of Growth
Dr. Jean-Luc Herbeaux appointed Chief Executive Officer of CordenPharma, effective 1 October 2026   Dr. Michael Quirmbach to transition from President & CEO to Board Member and Senior Advisor, ...
2026-09-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Ractigen Therapeutics to Present First-in-Human RNA Activation Data in Duchenne Muscular Dystrophy as a Late-Breaking Oral Presentation at the 31st Annual Congress of the World Muscle Society
Late-Breaking selection at the 31st Annual World Muscle Society Congress — a designation reserved for findings the program committee determines to be of immediate importance to the field Presentation ...
2026-09-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Natus Launches Locally Manufactured Nicolet EDX System in China
SUZHOU, China , Sept. 15, 2026 /PRNewswire/ -- Natus Medical Incorporated, the world's largest pure-play neurodiagnostic company, today announced the launch of the Nicolet EDX EMG system in the ...
2026-09-15T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Totaria Highlights Magnesium Nutrition Awareness During Healthy Aging Month
AURORA, Colo. , Sept. 15, 2026 /PRNewswire/ -- As September marks Healthy Aging Month  in the United States, premium American nutritional supplement brand Totaria is raising awareness about ...
2026-09-15T    Health Care/Hospital   Medical/Pharmaceuticals   Retail 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.